The idea of stem cell therapy has remained over-streamlined to a point where many people are getting deceived. This treatment aims at taking the donated cells and depositing them in a patient to help in treating an existing injury or disease. Learn more about Cameron Clokie: https://twitter.com/CameronClokie and https://thebrotalk.com/brotips/bros-dont-let-bros-bad-breath-toronto-oral-surgeon-cameron-clokie-helps-make-good-first-impression/
However, the reality is not as simple. According to Dr. Cameron Clokie, a regenerative medicine specialist, generative medicine takes up used cells, biomaterials and molecules to repair structures that are not functioning correctly in the body due to an illness or injury.
Numerous breakthroughs have been noted and appreciated in various scientific journals; nevertheless, the number of regenerative medicine treatments remains very low.
Only several successful therapies have made it to the patients, but some private hospitals are exploiting their patients’ desperation for treatment, by offering them untested therapies, worsening their conditions.
The main reason why the new therapy has not yet materialized despite the success and unrelenting efforts of the scientists to create new therapies is that regenerative medications have not yet developed into a conventional medical practice in many fields of medicine. Read more: Toronto Dentist Cameron Clokie Talks Up New Technology Available to Oral Surgeons
The Lancet Report indicated that there are lots of potentials to reduce the burden of diseases substantially specifically for some prevailing conditions such as stroke, heart disease, and advancing neurological conditions.
Besides that, it is also a proven fact that regenerative treatment can escalate life expectancy and enhance to a higher degree health-related life quality of patients suffering from chronic diseases.
As per The Lancet Report, it is a fact that cell therapy has been liable for the production of amazing clinical results that have spared the lives of many patients; although most of the cell therapies have faced variable, limited and transient efficacy.
Dr. Cameron is a scientist, oral and maxillofacial surgeon and a successful entrepreneur. He is the Chief Executive Officer of Biologics Inc., which is a generative medicine firm majoring on inventive resolutions for musculoskeletal restoration.
Dr. Clokie was active in clinical practice and academic dentistry for three decades, the recent ones being appointed the Head of Oral and Maxillofacial Surgery in 1998 and later as the Professor of Oral and Maxillofacial Surgery at the University of Toronto until 2017 when he retired from academics.
He has also assumed positions on scientific advisory panels of various companies.